apollo
logo
0Login
Introducing Our Latest Arrival!
Cfara 20 mg Injection 20 ml

Cfara 20 mg Injection 20 ml

Prescription drug
 Trailing icon
Consult Doctor

Composition

CLOFARABINE-20MG

Manufacturer/Marketer

Zydus Cadila

Consume Type

PARENTERAL

Return Policy

Not Returnable

for this medicine

About Cfara 20 mg Injection 20 ml

Cfara 20 mg Injection 20 ml is an anti-cancer medicine used in pediatric patients aged 1 - 21 years for the treatment of acute lymphoblastic leukaemia, a blood cancer that primarily affects the blood and bone marrow. Cfara 20 mg Injection 20 ml is used in patients with relapsed or refractory acute lymphoblastic leukaemia (ALL) after receiving at least two prior therapies.

Cfara 20 mg Injection 20 ml contains Clofarabine as an active ingredient in the class of antimetabolites. It works by inhibiting the DNA polymerase enzyme responsible for DNA elongation, synthesis, and repair.

Cfara 20 mg Injection 20 ml may cause certain side effects, such as skin rash, fatigue, headache, decreased platelet count, nausea, vomiting, diarrhoea, fever, anxiety, flushing, and injection site reactions. These side effects do not require medical attention and gradually resolve over time. A trained oncologist will administer Cfara 20 mg Injection 20 ml. Do not self-administer.

Cfara 20 mg Injection 20 ml should be avoided if you are allergic to it or any other components present in it. It should be used with caution in patients with a pre-existing or history of liver/kidney disease, gastrointestinal disorders, skin problems, and bleeding disorders, as it may cause serious side effects or worsen such conditions. This medicine is known to cause embryo-fetal toxicity. It is not recommended for use in pregnancy or breastfeeding.

Uses of Cfara 20 mg Injection 20 ml

Treatment of Acute lymphocytic leukemia (ALL)

Medicinal Benefits

Cfara 20 mg Injection 20 ml contains Clofarabine, which is used in the treatment of acute lymphoblastic leukemia (ALL). It works by inhibiting the DNA polymerase enzyme that is responsible for DNA elongation, synthesis, and repair. In general, it inhibits the production of genetic material (DNA) in the cancer cells that are essential for cell growth, repair and multiplication. Thus, Cfara 20 mg Injection 20 ml stops the multiplication of abnormal cells, leads to the growth of cells in an unbalanced way and causes the death of cells.

Directions for Use

A trained and experienced oncologist will administer Cfara 20 mg Injection 20 ml.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Cfara 20 mg Injection 20 ml

  • Nausea
  • Diarrhoea
  • Fatigue
  • Vomiting
  • Headache
  • Abdominal pain
  • Flushing
  • Skin rash
  • Fever
  • Rash
  • Itching
  • Pain at the site of injection
  • Injection site reactions

Drug Warnings

Cfara 20 mg Injection 20 ml should be avoided if you are allergic to it or any other components present in it. Before receiving, if the child has/had any history of liver/kidney disease, gastrointestinal disorders, skin problems, and bleeding disorders, as it may cause serious side effects or worsen such conditions. This medicine is known to cause embryo-fetal toxicity. Hence, inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment. Breastfeeding should be discontinued in nursing mothers during the treatment. Cfara 20 mg Injection 20 ml is given in children above one year of age only if prescribed by the doctor. Cfara 20 mg Injection 20 ml may cause myelosuppression, QT prolongation, hepatotoxicity, renal toxicity, cerebral, gastrointestinal and pulmonary haemorrhage, Tumor Lysis syndrome, severe infections, Systemic Inflammatory Response Syndrome (SIRS), enterocolitis, and skin reactions in some patients. Hence, inform your doctor about your complete medical and medication history before receiving this medicine.

Drug Interactions

Drug-Drug Interactions: Cfara 20 mg Injection 20 ml may interact with immunosuppressants (adalimumab, infliximab, natalizumab), antiviral medicine (saquinavir, efavirenz), live vaccines, antipsychotics (haloperidol, droperidol, clozapine), etc.

Drug-Food Interactions: No interactions found. 

Drug-Disease Interactions: Inform your doctor if you have kidney or liver disease, , diabetes, and skin disorders before receiving Cfara 20 mg Injection 20 ml.

Drug-Drug Interactions Checker List

  • ADALIMUMAB
  • NATALIZUMAB
  • INFLIXIMAB
  • EFAVIRENZ
  • HALOPERIDOL

Habit Forming

No

Diet & Lifestyle Advise

  • After beginning your treatment, several dietary adjustments can help you control side effects.
  • Anyone suffering from a chronic illness, including cancer, should consume foods high in protein, healthy fats, whole grains, and vitamins and minerals.
  • Plant-based proteins are among the greatest meals to take during chemotherapy or other cancer treatments. They have the highest concentrations of vitamins and minerals, such as nuts, seeds, beans, and legumes.
  • Eat a healthy diet and exercise regularly to maintain proper weight.
  • Include leafy vegetables, citrus fruits, fatty fish, berries, yoghurt, apples, peaches, cauliflower, cabbage, broccoli, beans, and herbs.
  • Get optimal sleep; rest well.
  • Avoid fast and fried food, processed meats, refined carbs and added sugars.

Special Advise

  • A blood test, such as LFT and RFT, should be performed to check for liver/kidney function.
  • Weekly blood tests should be done during the treatment to check for CBC (Complete blood count).
  • It is advised to use contraceptive pills while using Cfara 20 mg Injection 20 ml to prevent pregnancy.

Disease/Condition Glossary

Acute Lymphoblastic Leukemia (ALL): Leukemia, also known as blood cancer, is a cancer of blood cells or blood-forming tissues. It causes excessive production of immature white blood cells by the bone marrow and reduces the body’s ability to fight infections. There are different types of blood cancers. ALL is a type of blood cancer that primarily affects your blood and bone marrow. It mainly targets the white blood cells, which can interfere with your body’s ability to combat infections. Symptoms may include fever, weight loss, abnormal blood cell count, bruising, and loss of appetite.

bannner image

Alcohol

Unsafe

Avoid consuming alcohol while on treatment with Cfara 20 mg Injection 20 ml as it may cause severe side effects.

bannner image

Pregnancy

Unsafe

Cfara 20 mg Injection 20 ml is not recommended for use in pregnancy as it may cause embryo-fetal toxicity and harm your foetus. Hence, if you are under 21 and pregnant or planning pregnancy, inform your doctor before receiving Cfara 20 mg Injection 20 ml. You should not become pregnant while you are taking Cfara 20 mg Injection 20 ml. Using effective birth control methods while on treatment is suggested.

bannner image

Breast Feeding

Unsafe

There are no data on the presence of clofarabine in human milk, its effects on breastfed children, or its impact on milk supply; due to the possibility of serious adverse events in breastfed children, including genotoxicity, patients are advised not to breastfeed during therapy and for at least two weeks following the final dosage.

bannner image

Driving

Not applicable

Cfara 20 mg Injection 20 ml is administered to hospitalized patients.

bannner image

Liver

Caution

Cfara 20 mg Injection 20 ml has not been studied in patients with liver impairment. However, inform your doctor if you have liver problems.

bannner image

Kidney

Caution

If you have a history of kidney disease or have a pre-existing condition, notify your doctor before getting Cfara 20 mg Injection 20 ml. Based on your situation, your doctor may adjust the dose of this medication or prescribe a suitable alternative. Cfara 20 mg Injection 20 ml has the potential to cause renal toxicity, which presents as high creatinine levels and sudden renal failure. Monitor renal function and adjust or discontinue Clolar as needed.

bannner image

Children

Safe if prescribed

Cfara 20 mg Injection 20 ml is recommended for children and adolescents below 21 years of age only if prescribed by the oncologist.

Country of origin

India

Manufacturer/Marketer address

Zydus Tower, Satellite Cross Roads,Ahmedabad 380015 Gujarat, India.
Other Info - CFA0006

FAQs

Cfara 20 mg Injection 20 ml is used to treat Acute lymphocytic leukemia (ALL).
Cfara 20 mg Injection 20 ml contains Clofarabine, which works by inhibiting the DNA transcription that is essential for cancer cell growth. This helps prevent the growth and further spread of cancerous or non-cancerous cells.
Cfara 20 mg Injection 20 ml is used only in children and adolescents 1-21 years. It is not recommended for adults.
Treatment with Cfara 20 mg Injection 20 ml may result in cerebral, gastric, and pulmonary hemorrhage that is severe and fatal. Keep track of platelets and coagulation parameters and treat as needed.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.